Lessons from the '90s

Big Spenders

While companies endure this longest of biotech bear markets and watch their cash dwindle, it's important to remember that the money is there to be spent on turning science into products. While there's no guarantee that big spenders will use the money wisely, it can be said for certain that those who spend too little will get nowhere. Some of the bigger cash burners of the 1990s are now turning profits, or close to it, and their experiences provide some lessons for companies going through today's growing pains. ...